Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians
Open Access
- 23 June 2014
- journal article
- Published by Springer Nature in Thrombosis Journal
- Vol. 12 (1) , 13
Abstract
Atrial fibrillation (AF) is a common cardiac arrhythmia, and leading cause of ischemic stroke. Despite proven effectiveness, warfarin remains an under-used treatment in atrial fibrillation patients. We sought to study, across three physician specialties, a range of factors that have been argued to have a disproportionate effect on treatment decisions.Keywords
This publication has 51 references indexed in Scilit:
- Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with cliniciansJournal of Multidisciplinary Healthcare, 2012
- Use of warfarin in long-term care: a systematic reviewBMC Geriatrics, 2012
- New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary SyndromesJACC, 2012
- Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysisBMC Family Practice, 2012
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJACC, 2011
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationCirculation, 2011
- Barriers to Anticoagulation in Patients With Atrial FibrillationStroke, 2008
- Barriers to the Use of Anticoagulation for Nonvalvular Atrial FibrillationStroke, 2008
- Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocolImplementation Science, 2007
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006